Becton, Dickinson and Company (BD), founded in 1897 and headquartered in Franklin Lakes, New Jersey, USA, is a global medical technology company that develops, manufactures, and sells medical devices, instrument systems, and reagents. BD's extensive product portfolio includes syringes, needles, infusion therapy products, diagnostic instruments, and biosciences research tools, serving healthcare institutions, life science researchers, clinical laboratories, and the pharmaceutical industry. Committed to advancing the world of health, BD focuses on improving medical discovery, diagnostics, and the delivery of care. The company operates in more than 50 countries, employing approximately 70,000 associates worldwide.
BD and Wellstar Health System are integrating dispensing and infusion platforms to improve medication management, interoperability, and clinical workflow efficiency across hospital operations.
BD has commercially launched the CentroVena One Insertion System to consolidate central venous catheterization components into a single platform for improved clinical efficiency.
BD introduces HemoSphere Stream module to deliver real-time arterial waveform data on standard patient monitors across perioperative and critical care settings.
BD introduces automated dispensing and analytics platform in Europe to improve medication availability, safety, and operational efficiency in hospitals.
BD and Sinteco have partnered to integrate advanced robotics and connected technologies, automating medication packaging to reduce human error and improve patient care quality across Europe.
The collaboration targets large-volume subcutaneous biologics, aligning a 5.5 mL glass prefillable syringe with an existing autoinjector platform to support higher viscosity drug delivery.
BD presented new delivery technologies and testing services at Pharmapack 2026 to help pharmaceutical and biotech firms address complex biologic formulation challenges.